Literature DB >> 25297992

Tumor necrosis factor alpha and interleukin-6 facilitate corneal lymphangiogenesis in response to herpes simplex virus 1 infection.

Katie M Bryant-Hudson1, Hem R Gurung1, Min Zheng1, Daniel J J Carr2.   

Abstract

UNLABELLED: Herpes simplex virus 1 (HSV-1) is a common human pathogen of clinical significance due to its association with vision impairment and encephalitis. In a mouse model of ocular neovascularization, we have previously shown that HSV-1 elicits the genesis of lymphatic vessels into the cornea proper through epithelial cell expression of vascular endothelial growth factor A (VEGFA) dependent upon expression of VEGFR2 during acute infection. We hypothesized that other factors may be involved in lymphangiogenesis, with proinflammatory cytokines as the leading candidates. In the absence of infection or inflammation, intrastromal administration of tumor necrosis factor alpha (TNF-α) coupled with VEGFA elicited lymphatic vessel genesis significantly above either factor alone as well as a vehicle control. Consistent with this observation, anti-TNF-α antibody (Ab) blocked HSV-1-mediated corneal lymphangiogenesis within the first 5 days postinfection. However, TNF-α-deficient (TNF-α(-/-)) mice displayed a level of corneal vessel growth similar to that shown by wild-type (WT) controls. To investigate the likely redundant nature of cytokines, PCR array analysis of HSV-1-infected TNF-α(-/-) mice was conducted, and it revealed several factors elevated above those found in HSV-1-infected WT mice, including interleukin-1β (IL-1β), platelet-derived growth factor, angiopoietin 2, insulin-like growth factor 2, and IL-6. Subconjunctival administration of neutralizing Ab to IL-6 blocked lymphangiogenesis in TNF-α(-/-) mice. Whereas the cornea levels of IL-6 were significantly reduced, there was no appreciable change in the level of IL-1β or other proangiogenic factors analyzed. Collectively, the results suggest in addition to VEGFA, TNF-α and IL-6 promote and likely synergize with VEGFA in corneal lymphangiogenesis during acute HSV-1 infection. IMPORTANCE: We have identified at least two proinflammatory cytokines expressed locally that are involved in the genesis of lymphatic vessels in the normally avascular cornea in response to HSV-1 infection. This finding provides the basis to target IL-6 and TNF-α as additional proangiogenic factors in the cornea during the development of herpetic stromal keratitis as a means to alleviate further neovascularization and tissue pathology associated with the host immune response to the pathogen.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25297992      PMCID: PMC4249127          DOI: 10.1128/JVI.01841-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

Review 1.  Herpes simplex virus.

Authors:  Travis J Taylor; Mark A Brockman; Elizabeth E McNamee; David M Knipe
Journal:  Front Biosci       Date:  2002-03-01

2.  Dual functional roles of Tie-2/angiopoietin in TNF-alpha-mediated angiogenesis.

Authors:  Jian-Xiong Chen; Ying Chen; Laura DeBusk; Wenyu Lin; Pengnain Charles Lin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-07       Impact factor: 4.733

3.  IL-1 and TNF-alpha are important factors in the pathogenesis of murine recurrent herpetic stromal keratitis.

Authors:  T L Keadle; N Usui; K A Laycock; J K Miller; J S Pepose; P M Stuart
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-01       Impact factor: 4.799

4.  Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo.

Authors:  M Fràter-Schröder; W Risau; R Hallmann; P Gautschi; P Böhlen
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

5.  Epidemiology of ocular herpes simplex. Incidence in Rochester, Minn, 1950 through 1982.

Authors:  T J Liesegang; L J Melton; P J Daly; D M Ilstrup
Journal:  Arch Ophthalmol       Date:  1989-08

6.  Cytokine expression in vivo during murine herpetic stromal keratitis. Effect of protective antibody therapy.

Authors:  H F Staats; R N Lausch
Journal:  J Immunol       Date:  1993-07-01       Impact factor: 5.422

7.  Transgenic expression of interleukin-6 in the central nervous system confers protection against acute herpes simplex virus type-1 infection.

Authors:  D J Carr; I L Campbell
Journal:  J Neurovirol       Date:  1999-10       Impact factor: 2.643

Review 8.  Novel anti(lymph)angiogenic treatment strategies for corneal and ocular surface diseases.

Authors:  Felix Bock; Kazuichi Maruyama; Birgit Regenfuss; Deniz Hos; Philipp Steven; Ludwig M Heindl; Claus Cursiefen
Journal:  Prog Retin Eye Res       Date:  2013-01-22       Impact factor: 21.198

9.  Absence of tumour necrosis factor facilitates primary and recurrent herpes simplex virus-1 infections.

Authors:  Hiroko Minagawa; Koji Hashimoto; Yusuke Yanagi
Journal:  J Gen Virol       Date:  2004-02       Impact factor: 3.891

10.  Regional distribution of antibodies to herpes simplex virus type 1 (HSV-1) and HSV-2 in men and women in Ontario, Canada.

Authors:  Michelle Howard; John W Sellors; Dan Jang; Noah J Robinson; Margaret Fearon; Janusz Kaczorowski; Max Chernesky
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

View more
  25 in total

Review 1.  Macrophages: An Inflammatory Link Between Angiogenesis and Lymphangiogenesis.

Authors:  Bruce A Corliss; Mohammad S Azimi; Jennifer M Munson; Shayn M Peirce; Walter L Murfee
Journal:  Microcirculation       Date:  2016-02       Impact factor: 2.628

2.  Role of the DNA Sensor STING in Protection from Lethal Infection following Corneal and Intracerebral Challenge with Herpes Simplex Virus 1.

Authors:  Zachary M Parker; Aisling A Murphy; David A Leib
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

3.  IL-6 Contributes to Corneal Nerve Degeneration after Herpes Simplex Virus Type I Infection.

Authors:  Ana J Chucair-Elliott; Jeremy Jinkins; Meghan M Carr; Daniel J J Carr
Journal:  Am J Pathol       Date:  2016-08-03       Impact factor: 4.307

4.  Cooperative Effects of Vascular Angiogenesis and Lymphangiogenesis.

Authors:  Tatsuya Osaki; Jean C Serrano; Roger D Kamm
Journal:  Regen Eng Transl Med       Date:  2018-04-23

Review 5.  Pathogenesis of herpes simplex keratitis: The host cell response and ocular surface sequelae to infection and inflammation.

Authors:  Ann-Marie Lobo; Alex M Agelidis; Deepak Shukla
Journal:  Ocul Surf       Date:  2018-10-11       Impact factor: 5.033

Review 6.  Application of our understanding of pathogenesis of herpetic stromal keratitis for novel therapy.

Authors:  Naveen K Rajasagi; Barry T Rouse
Journal:  Microbes Infect       Date:  2018-01-09       Impact factor: 2.700

7.  Impact of Type I Interferon on the Safety and Immunogenicity of an Experimental Live-Attenuated Herpes Simplex Virus 1 Vaccine in Mice.

Authors:  Derek J Royer; Meghan M Carr; Ana J Chucair-Elliott; William P Halford; Daniel J J Carr
Journal:  J Virol       Date:  2017-03-13       Impact factor: 5.103

Review 8.  Therapeutic antibodies that target inflammatory cytokines in autoimmune diseases.

Authors:  Yuping Lai; Chen Dong
Journal:  Int Immunol       Date:  2015-11-06       Impact factor: 4.823

9.  Killing effect of TNF-mediated by conditionally replicating adenovirus on esophageal cancer and lung cancer cell lines.

Authors:  Yue-Quan Jiang; Zhi Zhang; Hua-Rong Cai; Hong Zhou
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

10.  Herpes Simplex Virus 1 (HSV-1) 0ΔNLS Live-Attenuated Vaccine Protects against Ocular HSV-1 Infection in the Absence of Neutralizing Antibody in HSV-1 gB T Cell Receptor-Specific Transgenic Mice.

Authors:  Grzegorz B Gmyrek; Adrian Filiberti; Micaela Montgomery; Alisha Chitrakar; Derek J Royer; Daniel J J Carr
Journal:  J Virol       Date:  2020-11-23       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.